BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36418402)

  • 1. Structural basis of tankyrase activation by polymerization.
    Pillay N; Mariotti L; Zaleska M; Inian O; Jessop M; Hibbs S; Desfosses A; Hopkins PCR; Templeton CM; Beuron F; Morris EP; Guettler S
    Nature; 2022 Dec; 612(7938):162-169. PubMed ID: 36418402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of tankyrase activity by a catalytic domain dimer interface.
    Fan C; Yarravarapu N; Chen H; Kulak O; Dasari P; Herbert J; Yamaguchi K; Lum L; Zhang X
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1780-1785. PubMed ID: 30055800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tankyrase Requires SAM Domain-Dependent Polymerization to Support Wnt-β-Catenin Signaling.
    Mariotti L; Templeton CM; Ranes M; Paracuellos P; Cronin N; Beuron F; Morris E; Guettler S
    Mol Cell; 2016 Aug; 63(3):498-513. PubMed ID: 27494558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural insights into SAM domain-mediated tankyrase oligomerization.
    DaRosa PA; Ovchinnikov S; Xu W; Klevit RE
    Protein Sci; 2016 Sep; 25(9):1744-52. PubMed ID: 27328430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tankyrase Sterile α Motif Domain Polymerization Is Required for Its Role in Wnt Signaling.
    Riccio AA; McCauley M; Langelier MF; Pascal JM
    Structure; 2016 Sep; 24(9):1573-81. PubMed ID: 27499439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragment-based screening identifies molecules targeting the substrate-binding ankyrin repeat domains of tankyrase.
    Pollock K; Liu M; Zaleska M; Meniconi M; Pfuhl M; Collins I; Guettler S
    Sci Rep; 2019 Dec; 9(1):19130. PubMed ID: 31836723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tankyrase polymerization is controlled by its sterile alpha motif and poly(ADP-ribose) polymerase domains.
    De Rycker M; Price CM
    Mol Cell Biol; 2004 Nov; 24(22):9802-12. PubMed ID: 15509784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tankyrases as drug targets.
    Lehtiö L; Chi NW; Krauss S
    FEBS J; 2013 Aug; 280(15):3576-93. PubMed ID: 23648170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution NMR assignment of the ARC4 domain of human tankyrase 2.
    Zaleska M; Pollock K; Collins I; Guettler S; Pfuhl M
    Biomol NMR Assign; 2019 Apr; 13(1):255-260. PubMed ID: 30847846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The zinc-binding motif in tankyrases is required for the structural integrity of the catalytic ADP-ribosyltransferase domain.
    Sowa ST; Lehtiö L
    Open Biol; 2022 Mar; 12(3):210365. PubMed ID: 35317661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of Wnt/β-catenin signalling by tankyrase-dependent poly(ADP-ribosyl)ation and scaffolding.
    Mariotti L; Pollock K; Guettler S
    Br J Pharmacol; 2017 Dec; 174(24):4611-4636. PubMed ID: 28910490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights of tankyrases: A novel target for drug discovery.
    Damale MG; Pathan SK; Shinde DB; Patil RH; Arote RB; Sangshetti JN
    Eur J Med Chem; 2020 Dec; 207():112712. PubMed ID: 32877803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc binding catalytic domain of human tankyrase 1.
    Lehtiö L; Collins R; van den Berg S; Johansson A; Dahlgren LG; Hammarström M; Helleday T; Holmberg-Schiavone L; Karlberg T; Weigelt J
    J Mol Biol; 2008 May; 379(1):136-45. PubMed ID: 18436240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vertebrate tankyrase domain structure and sterile alpha motif (SAM)-mediated multimerization.
    De Rycker M; Venkatesan RN; Wei C; Price CM
    Biochem J; 2003 May; 372(Pt 1):87-96. PubMed ID: 12589701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional analysis of parameters governing tankyrase-1 interaction with telomeric repeat-binding factor 1 and GDP-mannose 4,6-dehydratase.
    Eisemann T; Langelier MF; Pascal JM
    J Biol Chem; 2019 Oct; 294(40):14574-14590. PubMed ID: 31375564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for tankyrase-RNF146 interaction reveals noncanonical tankyrase-binding motifs.
    DaRosa PA; Klevit RE; Xu W
    Protein Sci; 2018 Jun; 27(6):1057-1067. PubMed ID: 29604130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tankyrase-targeted therapeutics: expanding opportunities in the PARP family.
    Riffell JL; Lord CJ; Ashworth A
    Nat Rev Drug Discov; 2012 Dec; 11(12):923-36. PubMed ID: 23197039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Poly(ADP-ribose) Polymerase Enzyme Tankyrase Antagonizes Activity of the β-Catenin Destruction Complex through ADP-ribosylation of Axin and APC2.
    Croy HE; Fuller CN; Giannotti J; Robinson P; Foley AVA; Yamulla RJ; Cosgriff S; Greaves BD; von Kleeck RA; An HH; Powers CM; Tran JK; Tocker AM; Jacob KD; Davis BK; Roberts DM
    J Biol Chem; 2016 Jun; 291(24):12747-12760. PubMed ID: 27068743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel binding mode of a potent and selective tankyrase inhibitor.
    Gunaydin H; Gu Y; Huang X
    PLoS One; 2012; 7(3):e33740. PubMed ID: 22438990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying and Validating Tankyrase Binders and Substrates: A Candidate Approach.
    Pollock K; Ranes M; Collins I; Guettler S
    Methods Mol Biol; 2017; 1608():445-473. PubMed ID: 28695526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.